tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sanofi’s Amlitelimab: Buy Rating Amid Challenges and Opportunities in Atopic Dermatitis Market
PremiumRatingsSanofi’s Amlitelimab: Buy Rating Amid Challenges and Opportunities in Atopic Dermatitis Market
9d ago
Sanofi upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Sanofi upgraded to Overweight from Equal Weight at Morgan Stanley
9d ago
Sanofi’s ‘disappointing’ atopic dermatitis data sends Nektar higher
Premium
The Fly
Sanofi’s ‘disappointing’ atopic dermatitis data sends Nektar higher
12d ago
Nektar jumps after Sanofi data misses expectations
PremiumThe FlyNektar jumps after Sanofi data misses expectations
12d ago
Sanofi amlitelimab data ‘well short of investor expectations,’ says BofA
Premium
The Fly
Sanofi amlitelimab data ‘well short of investor expectations,’ says BofA
12d ago
Sanofi says amlitelimab met primary, key secondary endpoints in Phase 3 study
Premium
The Fly
Sanofi says amlitelimab met primary, key secondary endpoints in Phase 3 study
13d ago
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe FlyBuy/Sell: Wall Street’s top 10 stock calls this week
25d ago
Novavax downgraded to Underperform at BofA on ‘murky outlook’
Premium
The Fly
Novavax downgraded to Underperform at BofA on ‘murky outlook’
28d ago
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
Premium
The Fly
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100